Tenaya Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TNYA and other ETFs, options, and stocks.

About TNYA

Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. Its programs include TN-201, TN-401, and TN-301. 

CEO
Faraz Ali
CEOFaraz Ali
Employees
97
Employees97
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2016
Founded2016
Employees
97
Employees97

TNYA Key Statistics

Market cap
163.09M
Market cap163.09M
Price-Earnings ratio
-0.94
Price-Earnings ratio-0.94
Dividend yield
Dividend yield
Average volume
3.21M
Average volume3.21M
High today
$0.77
High today$0.77
Low today
$0.70
Low today$0.70
Open price
$0.746
Open price$0.746
Volume
2.72M
Volume2.72M
52 Week high
$2.35
52 Week high$2.35
52 Week low
$0.36
52 Week low$0.36

Stock Snapshot

Tenaya Therapeutics(TNYA) stock is priced at $0.77, giving the company a market capitalization of 163.09M. It carries a P/E multiple of -0.94.

On 2026-01-13, Tenaya Therapeutics(TNYA) stock moved within a range of $0.70 to $0.77. With shares now at $0.77, the stock is trading +10.0% above its intraday low and 0.0% below the session's peak.

Trading activity shows a volume of 2.72M, compared to an average daily volume of 3.21M.

The stock's 52-week range extends from a low of $0.36 to a high of $2.35.

The stock's 52-week range extends from a low of $0.36 to a high of $2.35.

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own TNYA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .